Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.

Zhongbo Hu, Kristen A VanHeyst,Jignesh Dalal,Lisa Hackney

Clinical case reports（2021）

引用 0|浏览1

暂无评分

摘要

DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transient long-term remission after ALL relapse due to partial chemotherapy combined severe infection is rare.

查看译文

关键词

ALL R3,Down syndrome,Relapsed acute lymphoblastic leukemia,remission

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要